Soleno Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $41,384,000.

Profit Margin

Soleno Therapeutics, Inc. (NASDAQ:SLNO): Profit margin
2014 0 -13.87M
2015 387.55K -15.90M -4104.85%
2016 1.45M -12.06M -831.63%
2017 -1.55B -15.66M 1.01%
2018 0 -13.33M
2019 0 -35.91M
2020 0 -15.37M
2021 0 -29.56M
2022 0 -20.31M
2023 0 -38.98M

SLNO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000000-1.55B1.45M387.55K0
Cost of revenue
1.95M2.21M2.20M2.19M2.29M01.61M1.50M352.68K0
Gross profit
-1.95M-2.21M-2.20M-2.19M-2.29M0-1.55B-58.51K34.87K0
Operating exp.
Research and development
25.18M15.26M21.45M23.19M16.26M7.17M3.06M5.18M4.53M2.24M
Selling and marketing
00000025.73K1.63M1.73M252.35K
Total operating expenses
41.38M25.10M32.25M31.94M23.19M13.73M9.67M13.55M12.19M5.15M
Operating income
-41.38M-24.39M-31.52M-36.28M-23.48M-14.30M-12.17M-13.61M-12.15M-5.15M
Other income (expenses), net
2.39M330K618K11.65M-7.28M1.95M-1.27M1.56M-3.74M-8.07M
Income before tax
-38.98M-24.06M-30.91M-24.63M-30.77M-11.84M-13.72M-12.04M-15.90M-13.87M
Income tax expense
0-3.74M-1.34M-9.26M5.14M2.52M-1.65M21.7K-183.56K-455.08K
Net income
-38.98M-20.31M-29.56M-15.37M-35.91M-13.33M-15.66M-12.06M-15.90M-13.87M
Earnings per share
Basic EPS
-2.36-2.42-5.56-3.68-15.78-9.54-26.18-58.35-126.58-819.38
Diluted EPS
-2.36-2.42-5.56-3.68-15.78-9.54-26.18-58.35-126.58-819.38
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source